Discovering a Common Goal,
Discovering a Cure


Research News
Drug News
Conference News
< Home

Kinemed Receives U.S. Patent Allowance for Noscapine for ALS
September 4, 2014
Kinemed, Inc. has received a notice of allowance from the U.S. Patent and Trademark Office for their patent covering noscapine for treatment of ALS, PD and diabetic neuropathy. Thi...

Stephen Paul Joins as CEO of Voyager Therapeutics
September 3, 2014
Voyager Therapeutics, the Cambridge, MA-based gene therapy company launched by Third Rock Ventures earlier this year (see Feb 2014 news story), has appointed Stephen Paul, M.D. as ...

ALSTDI to Launch New ALS Clinical Trial With Ice Bucket Challenge Donations
August 27, 2014
The ALS Ice Bucket Challenge, the viral social media ALS fundraising campaign, has transformed the ALS funding landscape. How exactly the funds will be used to advance ALS researc...

Biogen Idec Appoints Donald Johns to Lead ALS Innovation Hub
August 26, 2014
Biogen Idec has appointed Donald Johns, M.D., as vice president and head of its ALS Innovation Hub (ALS iHub). The ALS iHub was established as a center of innovation to integrate r...

MediciNova to Begin Clinical Trial of MN-166(ibudilast) in ALS
August 25, 2014
MediciNova, a publicly-traded biopharmaceutical company based in La Jolla, California, has obtained FDA approval to initiate a clinical trial of MN-166 (ibudilast) for the treatmen...

The ALS Forum was developed by Prize4Life, Inc.
© 2014 Prize4Life, Inc.
Identified content provided through
a partnership with the Alzforum